# Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

> **NCT00290121** · PHASE4 · COMPLETED · sponsor: **Université de Montréal** · enrollment: 25 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00290121
- **Lead sponsor:** Université de Montréal
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290121, "Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00290121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*